Early lung cancer: surgery had fewer deaths at 3 years, radiation stays an option

If you or someone you love has early lung cancer, you may wonder whether surgery or radiation is the better path. A large new study from England found that people who had surgery were less likely to have died within three years than people who had radiation. It also supports radiation as a real treatment aimed at cure, especially for older people.

So the news is useful on both sides. Surgery still looks like the first choice when you are suited to it. Radiation is still a solid option when it fits you better.

Why was this study needed?

For early-stage non-small cell lung cancer, radiation is the standard treatment for people who cannot have surgery. The radiation type in this study is called stereotactic ablative radiotherapy, or SABR.

The harder question is what to choose when a person could have either one. Trials that assign people by chance to surgery or radiation have struggled to enroll enough patients. That left doctors with little direct evidence. This study tried to fill that gap using real-world records.

How the study worked

Researchers used England’s National Cancer Registry to find 12,546 people diagnosed between 2015 and 2020 with early-stage lung cancer who were suited to either treatment. Of those, 2,299 had SABR and 10,247 had surgery, and the team compared what happened over three years. The study was published on November 2, 2026, in the Journal of Clinical Oncology, and because it used registry records rather than assigning treatments by chance, it can show links but cannot prove cause, even though the researchers used a method to make the two groups more comparable.

What they found

After adjusting for differences between the groups, about 30 out of every 100 people in the radiation group had died from any cause within three years. In the surgery group, it was about 22 out of every 100. The exact figures were 30.3% for radiation and 21.6% for surgery, a gap of 8.8 percentage points.

The researchers also looked at deaths from lung cancer itself. Those were 20.6% after radiation and 14.5% after surgery. That gap, 6.1 points, was small enough that it could be down to chance.

Here is the part many readers will care about. Among people age 80 and older, the gap in deaths from any cause was 4.3 points. That was too small to tell apart from chance. In other words, for older adults, this study did not find a clear difference between the two treatments.

The authors concluded that surgery should remain the preferred option for people who are suited to either treatment. They also said the findings support radiation as an alternative meant to cure the cancer, particularly for older people.

What you can do today

If you or a family member is facing this choice, write down three questions before the next appointment. Ask whether you are suited to both surgery and radiation, what each option would mean for your daily life, and how your age and overall health fit in. Bring the list with you and take notes on the answers, so the decision feels like yours.